tiprankstipranks
Trending News
More News >
Hypha Labs (FUNI)
OTHER OTC:FUNI
US Market

Hypha Labs (FUNI) Price & Analysis

Compare
10 Followers

FUNI Stock Chart & Stats


---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.90%94.10%
Mutual Funds
― Other Institutional Investors
94.10% Public Companies and
Individual Investors

FUNI FAQ

What was Hypha Labs’s price range in the past 12 months?
Hypha Labs lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
    What is Hypha Labs’s market cap?
    Hypha Labs’s market cap is $3.68M.
      When is Hypha Labs’s upcoming earnings report date?
      Hypha Labs’s upcoming earnings report date is Feb 18, 2025 which is 72 days ago.
        How were Hypha Labs’s earnings last quarter?
        Hypha Labs released its earnings results on Feb 13, 2024. The company reported $0.002 earnings per share for the quarter, beating the consensus estimate of N/A by $0.002.
          Is Hypha Labs overvalued?
          According to Wall Street analysts Hypha Labs’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Hypha Labs pay dividends?
            Hypha Labs does not currently pay dividends.
            What is Hypha Labs’s EPS estimate?
            Hypha Labs’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Hypha Labs have?
            Hypha Labs has 127,046,820 shares outstanding.
              What happened to Hypha Labs’s price movement after its last earnings report?
              Hypha Labs reported an EPS of $0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Hypha Labs?
                Currently, no hedge funds are holding shares in FUNI
                ---

                Company Description

                Hypha Labs

                DigiPath, Inc. engages in the provision of cannabis testing, education, training, and news coverage. It operates through the Digipath Labs and GroSciences business units. The Digipath Labs business unit focuses on testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures. The GroSciences business unit plans to develop and license specific formulations to other producers and product makers in the industry. The company was founded by Todd Denkin on October 5, 2010 and is headquartered in Las Vegas, NV.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Xylo Technologies Ltd
                Mustang Bio
                PainReform
                Synaptogenix
                Longevity Health Holdings
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis